HOME >> MEDICINE >> NEWS
Actonel reduced nonveterbral fracture as early as 6 months

ill experience a fracture due to osteoporosis in their lifetimes. Postmenopausal osteoporosis, is the most common form of osteoporosis.

About Actonel (risedronate sodium tablets)
Actonel is co-developed and co-marketed by Procter & Gamble Pharmaceuticals and Aventis Pharmaceuticals. Actonel 35 mg once-a-week and Actonel 5 mg daily are indicated for the prevention and treatment of osteoporosis in postmenopausal women. Actonel 5 mg daily is also indicated for the prevention and treatment of glucocorticoid-induced osteoporosis (GIO) in men and women either initiating or continuing systemic glucocorticoid treatment (? 7.5 mg/d prednisone or equivalent) for chronic diseases.

In clinical trials, Actonel was generally well tolerated. Actonel is contraindicated in patients with hypocalcemia, known hypersensitivity to any component of this product, or inability to stand or sit upright for at least 30 minutes. Hypocalcemia and other disturbances of bone and mineral metabolism should be effectively treated before starting Actonel therapy. Actonel is not recommended for use in patients with severe renal impairment (creatinine clearance < 30 mL/min).

Bisphosphonates may cause upper gastrointestinal disorders such as dysphagia, esophagitis and esophageal or gastric ulcer. Patients should pay particular attention to the dosing instructions, as failure to take the drug according to instructions may compromise clinical benefits and may increase the risk of adverse events.

In clinical trials, the overall incidence of adverse events with Actonel 5 mg daily was comparable to placebo. The most commonly reported adverse events regardless of causality were infection (primarily upper respiratory, placebo 29.7 percent vs. Actonel 5 mg 29.9 percent), back pain (23.6 percent vs. 26.1 percent), and arthralgia (21.1 percent vs. 23.7 percent).

In a one-year clinical trial comparing Actonel 35 mg once-a-week and Actonel 5 m
'"/>

Contact: Brian Devenny
bdevenny@hillandknowlton.com
212-885-0315
Hill and Knowlton
21-Jun-2002


Page: 1 2 3

Related medicine news :

1. Actonel helped preserve bone quality at five years, new data show
2. New analysis shows early intervention with Actonel reduces first vertebral fracture risk
3. FDA approves Actonel for once-a-week use
4. Study shows Actonel reduces vertebral fracture risk 70 percent in patients on chronic steroid therapy
5. Study shows use of budesonide reduced the risk of asthma related events by 40% in children
6. Hypothyroidism associated with reduced breast cancer risk
7. Cocaine addicts show reduced brain structure that underlies judgment
8. Breast cancer risk, prognosis and weight gain reduced with physical activity
9. New analysis links breastfeeding to reduced risk of childhood leukemia
10. Teenage hormone therapy to reduce adult height of tall girls linked to reduced fertility
11. Biopharmaceutical manufacturing efficiencies signal reduced healthcare costs

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/13/2018)... ... November 13, 2018 , ... Today, MIT-born startup Atolla ... monthly subscription kit includes at home skin analysis tools for measuring oil, moisture, ... proprietary algorithm formulates the serum to combat a user’s specific skin issues (such ...
(Date:11/13/2018)... DIEGO (PRWEB) , ... November 13, 2018 , ... 2018 ... innovations in search results, there’s a lot for marketers to prepare for in the ... technology is the widespread adoption of AI. Most notably, AI is having a major ...
(Date:11/13/2018)... ... November 13, 2018 , ... RoosterBio ... and hMSC-specific bioprocess systems, announces today it has submitted a U.S. Food and ... cGMP hMSC working cell banks. This MF complements the MF for the CliniControl ...
(Date:11/13/2018)... (PRWEB) , ... November 13, 2018 , ... ... & Construction (EPC) company, announced that it has been named to Boston Business ... for the third consecutive year. This time, Beaumont Solar, through significant ...
(Date:11/13/2018)... ... November 13, 2018 , ... ... BTG has invested $20m in Veran Medical Technologies, Inc. and has an option ... healthcare company focused on Interventional Medicine. Their innovative medical technology helps physicians treat ...
Breaking Medicine News(10 mins):
(Date:11/13/2018)... ... November 13, 2018 , ... New Cleveland Clinic ... who have previously undergone weight-loss or bariatric surgery, and later suffer unrelated heart ... not have surgery, according to a new study from Cleveland Clinic researchers ...
(Date:11/13/2018)... ... November 13, 2018 , ... Society has always been told ... Unfortunately, regular chairs that maintain a 90-degree angle between the back and thighs do ... impossible to achieve correct spinal positioning when sitting in a typical chair — the ...
(Date:11/13/2018)... ... November 13, 2018 , ... The Healthcare Linen Alliance ... business development and partnerships. Rick has spent much of his career in the ... to Sales, Rick brings his extensive background in the industry to the team. ...
Breaking Medicine Technology:
Cached News: